Dupilumab Consistently Improves Rhinoconjunctivitis-Specific Health-Related Quality of Life in Patients With Uncontrolled, Moderate-To-Severe Asthma and Comorbid Allergic Rhinitis: Results From the Phase 3 LIBERTY ASTHMA QUEST Study

Journal of Allergy and Clinical Immunology - United States

doi 10.1016/j.jaci.2018.12.307